Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Morari

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Journal of Neuroinflammation|October 29, 2018
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4Isabella Russo, Giulietta Di Benedetto, Alice Kaganovich, et al.
Neurobiology of Disease|April 28, 2012
Loss of cortical GABA terminals in Unverricht-Lundborg diseaseAndrea Buzzi, Maia Chikhladze, Chiara Falcicchia, et al.
The European Journal of Neuroscience|March 16, 2004
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortexFlora Mela, Matteo Marti, Linda Ulazzi, et al.
Scientific Reports|January 17, 2014
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatumGregory Porras, Philippe De Deurwaerdere, Qin Li, et al.
ACS Chemical Neuroscience|April 25, 2013
GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic ratsOmar S Mabrouk, Flora Mela, Mariangela Calcagno, et al.
Molecular Neurobiology|December 22, 2015
Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent MechanismLouise M Collins, Giorgia Dal Bo, Mariangela Calcagno, et al.
Frontiers in Cell and Developmental Biology|October 2, 2019
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein SignalingMartina Mazzocchi, Sean L Wyatt, Daniela Mercatelli, et al.
Neurobiology of Disease|January 26, 2016
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's diseaseLudovico Arcuri, Riccardo Viaro, Simone Bido, et al.
Pharmaceutical Research|January 4, 2008
Solid lipid nanoparticles as delivery systems for bromocriptineElisabetta Esposito, Martina Fantin, Matteo Marti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 18, 2002
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneuronsAntonio Pisani, Paola Bonsi, Maria Vincenza Catania, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Journal of Neuroinflammation|October 29, 2018
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4Isabella Russo, Giulietta Di Benedetto, Alice Kaganovich, et al.
Neurobiology of Disease|April 28, 2012
Loss of cortical GABA terminals in Unverricht-Lundborg diseaseAndrea Buzzi, Maia Chikhladze, Chiara Falcicchia, et al.
The European Journal of Neuroscience|March 16, 2004
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortexFlora Mela, Matteo Marti, Linda Ulazzi, et al.
Scientific Reports|January 17, 2014
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatumGregory Porras, Philippe De Deurwaerdere, Qin Li, et al.
ACS Chemical Neuroscience|April 25, 2013
GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic ratsOmar S Mabrouk, Flora Mela, Mariangela Calcagno, et al.
Molecular Neurobiology|December 22, 2015
Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent MechanismLouise M Collins, Giorgia Dal Bo, Mariangela Calcagno, et al.
Frontiers in Cell and Developmental Biology|October 2, 2019
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein SignalingMartina Mazzocchi, Sean L Wyatt, Daniela Mercatelli, et al.
Neurobiology of Disease|January 26, 2016
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's diseaseLudovico Arcuri, Riccardo Viaro, Simone Bido, et al.
Pharmaceutical Research|January 4, 2008
Solid lipid nanoparticles as delivery systems for bromocriptineElisabetta Esposito, Martina Fantin, Matteo Marti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 18, 2002
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneuronsAntonio Pisani, Paola Bonsi, Maria Vincenza Catania, et al.
Pageof 10